Abstract
d-amino acids are now recognized to be widely present in organisms and play essential roles in biological processes. Some d-amino acids are metabolized by d-amino acid oxidase (DAO), while d-Asp and d-Glu are metabolized by d-aspartate oxidase (DDO). In this study, levels of 22 amino acids and the enantiomeric compositions of the 19 chiral proteogenic entities have been determined in the whole brain of wild-type ddY mice (ddY/DAO+/+), mutant mice lacking DAO activity (ddY/DAO−/−), and the heterozygous mice (ddY/DAO+/−) using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). No significant differences were observed for l-amino acid levels among the three strains except for l-Trp which was markedly elevated in the DAO+/− and DAO−/− mice. The question arises as to whether this is an unknown effect of DAO inactivity. The three highest levels of l-amino acids were l-Glu, l-Asp, and l-Gln in all the three strains. The lowest l-amino acid level was l-Cys in ddY/DAO+/− and ddY/DAO−/− mice, while l-Trp showed the lowest level in ddY/DAO+/+mice. The highest concentration of d-amino acid was found to be d-Ser, which also had the highest % d value (~ 25%). d-Glu had the lowest % d value (~ 0.01%) in all the three strains. Significant differences of d-Leu, d-Ala, d-Ser, d-Arg, and d-Ile were observed in ddY/DAO+/− and ddY/DAO−/− mice compared to ddY/DAO+/+ mice. This work provides the most complete baseline analysis of l- and d-amino acids in the brains of ddY/DAO+/+, ddY/DAO+/−, and ddY/DAO−/− mice yet reported. It also provides the most effective and efficient analytical approach for measuring these analytes in biological samples. This study provides fundamental information on the role of DAO in the brain and may be relevant for future development involving novel drugs for DAO regulation.
Similar content being viewed by others
References
Auclair JL, Patton RL. On the occurrence of D-alanine in the haemolymph of the milkweed bug, Oncopeltus fasciatus. Rev Can Biol. 1950;9:3–8.
Stevens CM, Halpern PE, Gigger RP. Occurrence of D-amino acids in some natural materials. J Biol Chem. 1951;190:705–10.
Corrigan JJ. D-amino acids in animals. Science. 1969;164:142–9.
Robinson T. D-amino acids in higher plants. Life Sci. 1976;19:1097–102.
Armstrong DW, Duncan JD, Lee SH. Evaluation of D-amino acid levels in human urine and in commercial L-amino acid samples. Amino Acids. 1991;1:97–106.
Armstrong DW, Gasper M, Lee SH, Zukowski J, Ercal N. D-amino acid levels in human physiological fluids. Chirality. 1993;5:375–8.
Kullman JP, Chen X, Armstrong DW. Evaluation of the enantiomeric composition of amino acids in tobacco. Chirality. 1999;11:669–73.
Kreil G. D-amino acids in animal peptides. Annu Rev Biochem. 1997;66:337–45.
Ollivaux C, Soyez D, Toullec J-Y. Biogenesis of D-amino acid containing peptides/proteins: where, when and how? J Pept Sci. 2014;20:595–612.
Armstrong DW, Zukowski J, Ercal N, Gasper M. Stereochemistry of pipecolic acid found in the urine and plasma of subjects with peroxisomal deficiencies. J Pharm Biomed Anal. 1993;11:881–6.
Schell MJ, Brady RO Jr, Molliver ME, Snyder SH. D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J Neurosci. 1997;17:1604–15.
Mothet JP, Parent AT, Wolosker H, Brady RO, Jr., Linden DJ, Ferris CD et al. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 2000;97:4926–4931.
Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H, et al. A Csf and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr Res. 2007;90:41–51.
Madeira C, Freitas ME, Vargas-Lopes C, Wolosker H, Panizzutti R. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr Res. 2008;101:76–83.
Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N, et al. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry. 2003;60:572–6.
Tsai GE, Yang P, Chang Y-C, Chong M-Y. D-alanine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry. 2006;59:230–4.
Errico F, Nistico R, Napolitano F, Mazzola C, Astone D, Pisapia T, et al. Increased D-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice. Neurobiol Aging. 2011;32:2229–43.
D'Aniello A, Lee JM, Petrucelli L, Di Fiore MM. Regional decreases of free D-aspartate levels in Alzheimer’s disease. Neurosci Lett. 1998;250:131–4.
Newcomer JW, Farber NB, Olney JW. NMDA receptor function, memory, and brain aging. Dialogues Clin Neurosci. 2000;2:219–32.
Moaddel R, Luckenbaugh DA, Xie Y, Villasenor A, Brutsche NE, Machado-Vieira R, et al. D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression. Psychopharmacology. 2015;232:399–409.
Hartman AL, Santos P, O'Riordan KJ, Stafstrom CE, Hardwick JM. Potent anti-seizure effects of D-leucine. Neurobiol Dis. 2015;82:46–53.
Holden K, Hartman AL. D-leucine: evaluation in an epilepsy model. Epilepsy Behav. 2018;78:202–9.
Weatherly CA, Du S, Parpia C, Santos PT, Hartman AL, Armstrong DW. D-amino acid levels in perfused mouse brain tissue and blood: a comparative study. ACS Chem Neurosci. 2017;8:1251–61.
Yoshimura T, Esak N. Amino acid racemases: functions and mechanisms. J Biosci Bioeng. 2003;96:103–9.
Wolosker H, Sheth KN, Takahashi M, Mothet JP, Brady RO Jr, Ferris CD, et al. Purification of serine racemase: biosynthesis of the neuromodulator D-serine. Proc Natl Acad Sci U S A. 1999;96:721–5.
Kim PM, Duan X, Huang AS, Liu CY, Ming GL, Song H, et al. Aspartate racemase, generating neuronal D-aspartate, regulates adult neurogenesis. Proc Natl Acad Sci U S A. 2010;107:3175–9.
Krebs HA. Metabolism of amino-acids: deamination of amino-acids. Biochem J. 1935;29:1620–44.
Pollegioni L, Piubelli L, Sacchi S, Pilone MS, Molla G. Physiological functions of D-amino acid oxidases: from yeast to humans. Cell Mol Life Sci. 2007;64:1373–94.
Sacchi S, Caldinelli L, Cappelletti P, Pollegioni L, Molla G. Structure-function relationships in human D-amino acid oxidase. Amino Acids. 2012;43:1833–50.
Hamase K, Inoue T, Morikawa A, Konno R, Zaitsu K. Determination of free D-proline and D-leucine in the brains of mutant mice lacking D-amino acid oxidase activity. Anal Biochem. 2001;298:253–8.
Morikawa A, Hamase K, Inoue T, Konno R, Niwa A, Zaitsu K. Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino-acid oxidase activity. J Chromatogr B. 2001;757:119–25.
Sasaki M, Konno R, Nihio M, Niwa A, Yasumura Y, Enami J. A single-base-pair substitution abolishes D-amino-acid oxidase activity in the mouse. Biochim Biophys Acta (BBA) - Mol Basis Dis. 1992;1139:315–8.
Huxtable RJ. Physiological actions of taurine. Physiol Rev. 1992;72:101–63.
Kontro P, Marnela KM, Oja SS. GABA, taurine and hypotaurine in developing mouse brain. Acta Physiol Scand Suppl. 1984;537:71–4.
Petroff OA. GABA and glutamate in the human brain. Neuroscientist. 2002;8:562–73.
Pawlowska M, Chen S, Armstrong DW. Enantiomeric separation of fluorescent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, tagged amino acids. J Chromatogr A. 1993;641:257–65.
Patel DC, Breitbach ZS, Yu J, Nguyen KA, Armstrong DW. Quinine bonded to superficially porous particles for high-efficiency and ultrafast liquid and supercritical fluid chromatography. Anal Chim Acta. 2017;963:164–74.
Armstrong DW, Liu Y, Ekborgott KH. A covalently bonded teicoplanin chiral stationary phase for HPLC enantioseparations. Chirality. 1995;7:474–97.
Karlsson C, Karlsson L, Armstrong DW, Owens PK. Evaluation of a vancomycin chiral stationary phase in capillary electrochromatography using polar organic and reversed-phase modes. Anal Chem. 2000;72:4394–401.
Péter A, Vékes E, Armstrong DW. Effects of temperature on retention of chiral compounds on a ristocetin A chiral stationary phase. J Chromatogr A. 2002;958:89–107.
US-FDA. Guidance for industry-bioanalytic method validation. 2001.
Miyoshi Y, Hamase K, Tojo Y, Mita M, Konno R, Zaitsu K. Determination of D-serine and D-alanine in the tissues and physiological fluids of mice with various D-amino-acid oxidase activities using two-dimensional high-performance liquid chromatography with fluorescence detection. J Chromatogr B. 2009;877:2506–12.
Suzuki S, Mori A. Regional distribution of tyrosine, tryptophan, and their metabolites in the brain of epileptic el mice. Neurochem Res. 1992;17:693–8.
Albrecht J, Sidoryk-Wegrzynowicz M, Zielinska M, Aschner M. Roles of glutamine in neurotransmission. Neuron Glia Biol. 2010;6:263–76.
Wu J-Y, Prentice H. Role of taurine in the central nervous system. J Biomed Sci. 2010;17:S1–S.
Okamoto K, Kimura H, Sakai Y. Taurine-induced increase of the Cl-conductance of cerebellar Purkinje cell dendrites in vitro. Brain Res. 1983;259:319–23.
Le Floc’h N, Otten W, Merlot E. Tryptophan metabolism, from nutrition to potential therapeutic applications. Amino Acids. 2011;41:1195–205.
Pardridge WM. Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids. Neurochem Res. 1998;23:635–44.
Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science. 1972;178:414–6.
Silber BY, Schmitt JAJ. Effects of tryptophan loading on human cognition, mood, and sleep. Neurosci Biobehav Rev. 2010;34:387–407.
Pritchett D, Hasan S, Tam SK, Engle SJ, Brandon NJ, Sharp T, et al. D-amino acid oxidase knockout (DAO(−/−) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption. Eur J Neurosci. 2015;41:1167–79.
Frick A, Åhs F, Engman J, et al. Serotonin synthesis and reuptake in social anxiety disorder: a positron emission tomography study. JAMA Psychiatry. 2015;72:794–802.
Navarro E, Alonso SJ, Martin FA, Castellano MA. Toxicological and pharmacological effects of D-arginine. Basic Clin Pharmacol Toxicol. 2005;97:149–54.
D'Aniello A, D'Onofrio G, Pischetola M, D'Aniello G, Vetere A, Petrucelli L, et al. Biological role of D-amino acid oxidase and D-aspartate oxidase. Effects of D-amino acids. J Biol Chem. 1993;268:26941–9.
Adage T, Trillat A-C, Quattropani A, Perrin D, Cavarec L, Shaw J, et al. In vitro and in vivo pharmacological profile of As057278, a selective D-amino acid oxidase inhibitor with potential anti-psychotic properties. Eur Neuropsychopharmacol. 2008;18:200–14.
Acknowledgements
We would like to thank Dr. Adam L. Hartman (NIH and JHUSOM) for providing the mouse brain samples for this study, and the ddY mice used in this study were a kind gift from Thomas N. Seyfried (Boston College) to Dr. Hartman. We are also grateful to Dr. Hartman for his assistance with the statistical analysis and comments that greatly improved the manuscript. We thank AZYP, LLC, for their technical support for HPLC chiral column technology. We would also like to thank the Shimadzu Center for Advanced Analytical Chemistry for the use of the Shimadzu instrument (LCMS-8040).
Funding
This work was supported by the Robert A. Welch Foundation (Y0026) (DWA).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was carried out under experimental protocols approved by the Johns Hopkins Institution Animal Care and Use Committee.
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
ESM 1
(PDF 184 kb)
Rights and permissions
About this article
Cite this article
Du, S., Wang, Y., Weatherly, C.A. et al. Variations of l- and d-amino acid levels in the brain of wild-type and mutant mice lacking d-amino acid oxidase activity. Anal Bioanal Chem 410, 2971–2979 (2018). https://doi.org/10.1007/s00216-018-0979-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-018-0979-9